Cargando…

Impact of late administration of corticosteroids in COVID-19 ARDS

Detalles Bibliográficos
Autores principales:	Mongardon, Nicolas, Piagnerelli, Michael, Grimaldi, David, Perrot, Bastien, Lascarrou, Jean-Baptiste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645397/ https://www.ncbi.nlm.nih.gov/pubmed/33156381 http://dx.doi.org/10.1007/s00134-020-06311-z

Ejemplares similares

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study
por: Vandenbunder, Benoit, et al.
Publicado: (2021)

Corticosteroids in H1N1, non-viral, and COVID-19 ARDS
por: Kwon, Kyoung-Eun, et al.
Publicado: (2022)

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020)

Corticosteroids in ARDS
por: Kuperminc, Emmanuelle, et al.
Publicado: (2023)

Barotrauma in COVID-19 acute respiratory distress syndrome: retrospective analysis of the COVADIS prospective multicenter observational database
por: Serck, Nicolas, et al.
Publicado: (2023)

Correction: Barotrauma in COVID-19 acute respiratory distress syndrome: retrospective analysis of the COVADIS prospective multicenter observational database
por: Serck, Nicolas, et al.
Publicado: (2023)

Early administration of corticosteroids and mortality
por: Sprung, Charles L, et al.
Publicado: (2012)

Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study
por: Mesland, Jean-Baptiste, et al.
Publicado: (2022)

Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS
por: Lamouche-Wilquin, Pauline, et al.
Publicado: (2022)

Steroids in late ARDS?
por: Wajanaponsan, Non, et al.
Publicado: (2007)

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
por: Chaudhuri, Dipayan, et al.
Publicado: (2021)

Transpulmonary pressures in obese and non-obese COVID-19 ARDS
por: Mezidi, Mehdi, et al.
Publicado: (2020)

Practice patterns in the administration of late preterm antenatal corticosteroids
por: Gulersen, Moti, et al.
Publicado: (2021)

Severe Covid-19 disease: rather AVDS than ARDS?
por: Mahjoub, Yazine, et al.
Publicado: (2020)

Early bacterial co-infection in ARDS related to COVID-19
por: Kreitmann, Louis, et al.
Publicado: (2020)

Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS
por: Jouan, Youenn, et al.
Publicado: (2021)

RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Tsolaki, Vasiliki, et al.
Publicado: (2021)

Timing of Intubation in Covid-19 ARDS: What “time” really matters?
por: Tsolaki, Vasiliki, et al.
Publicado: (2021)

Reinventing the Wheel in ARDS: Awake Proning in COVID-19
por: Sryma, P.B., et al.
Publicado: (2020)

High‐dose, short‐term corticosteroids for ARDS caused by COVID‐19: a case series
por: So, Clara, et al.
Publicado: (2020)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

Corticosteroids and ARDS: A review of treatment and prevention evidence
por: Khilnani, G.C., et al.
Publicado: (2011)

COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021)

Impact of HFOV in pARDS outcomes: questions remain
por: Kanthimathinathan, Hari Krishnan, et al.
Publicado: (2020)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Bleakley, Caroline, et al.
Publicado: (2021)

Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients
por: Soumagne, Thibaud, et al.
Publicado: (2020)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022)

Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)

Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS
por: Reizine, F., et al.
Publicado: (2022)

Renal failure in COVID-19 ARDS: Could it be partially avoided?
por: Zakynthinos, George E., et al.
Publicado: (2021)

Corticosteroid administration for viral pneumonia: COVID-19 and beyond
por: Yang, J.-W., et al.
Publicado: (2020)

Oxygen administration for patients with ARDS
por: Ohshimo, Shinichiro
Publicado: (2021)

Using the lung ultrasound score to monitor disease progression for COVID-19-associated ARDS
por: Nguyen, Maxime, et al.
Publicado: (2021)

Differential effects of prone position in COVID-19-related ARDS in low and high recruiters
por: Cour, Martin, et al.
Publicado: (2021)

Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
por: Vargas, Maria, et al.
Publicado: (2021)

Simultaneous ventilation of two simulated ARDS patients in COVID-19 pandemic
por: Epstein, Danny, et al.
Publicado: (2020)

Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study
por: Tsai, Ming-Ju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nfveslg96b6t7e91vtjvosb0vu